Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2000
03/01/2000CN1246033A Hexahydroindenopyridine compounds having antispermatogenic activity
03/01/2000CN1245713A Chinese medicine prescription special for enriching milk secretion
03/01/2000CN1245708A Medicine for external application for curing gynecopathy
02/2000
02/29/2000US6031072 Compounds and methods for modulating cell adhesion
02/29/2000US6030946 Reversible cysteine protease inhibitors
02/29/2000US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents
02/29/2000US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
02/24/2000WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2
02/24/2000WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
02/24/2000WO2000009136A1 Progestogen-only contraceptive kit providing good cycle control
02/24/2000WO2000009134A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women
02/24/2000WO1999059525A3 Broad spectrum microbicidal and spermicidal compositions, devices, and methods
02/24/2000WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
02/24/2000CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2
02/23/2000EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/23/2000EP0980369A1 Sulfonamides for treatment of endothelin-mediated disorders
02/23/2000EP0980245A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction
02/23/2000CN1245436A Pharmaceutical formulations for sustained drug delivery
02/23/2000CN1245071A Medicine for treating cervical erosion
02/23/2000CN1049660C Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them
02/23/2000CN1049654C Piperazine derivatives and medicine composition containing same and use thereof
02/22/2000US6028057 Inducing pseudopregnancy in fertile female pigs comprising administering to the pigs an effective amount of a compound that induces pseudopregnancy in a biodegradable controlled release formulation
02/22/2000US6027927 Human trk receptors and neurotrophic factor inhibitors
02/22/2000US6027905 Methods for the detection of cervical cancer
02/22/2000US6027727 Inducing transient infertility in a mammal by administering a dose of recombinant zona pellicida proteins from a cat, cattle or cynomolgous monkey and human to stimulate antibody production; vaccines
02/17/2000WO2000008150A1 Method for treatment of invasive cells
02/17/2000WO2000008015A2 Fsh mimetics for the treatment of infertility
02/17/2000WO2000007997A1 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS
02/17/2000WO2000007994A1 Novel bi- and tri-cyclic aza compounds and their uses
02/17/2000WO2000007599A1 Prevention of endometriosis signs or symptoms
02/17/2000WO2000007597A1 Transmucosal therapeutic system for administering sildenafil
02/17/2000WO2000007596A1 Water-soluble pharmaceutical formulation for administering sildenafil
02/17/2000WO2000007595A1 Pyridinones for the treatment of sexual dysfunction
02/17/2000WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
02/17/2000WO2000007542A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p
02/17/2000WO1999063931A3 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
02/17/2000DE19836697A1 New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes
02/17/2000CA2339484A1 Pyridinones for the treatment of sexual dysfunction
02/17/2000CA2339413A1 Method for treatment of invasive cells
02/17/2000CA2339122A1 Novel bi- and tri-cyclic aza compounds and their uses
02/17/2000CA2339086A1 Dna replication- and repair-associated proteins
02/17/2000CA2339018A1 Fsh mimetics for the treatment of infertility
02/17/2000CA2338594A1 Imidazoles and related compounds as .alpha.1a agonists
02/17/2000CA2338385A1 Human receptor-associated proteins
02/17/2000CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
02/16/2000EP0979098A1 Method of treating hyperprolactinemia and prolactinomas
02/16/2000EP0979074A1 Treatment or prevention of menopausal symptoms and osteoporosis
02/16/2000CN1244863A Novel benzopyran derivatives
02/16/2000CN1049335C Medicinal use of benzothiophene compounds
02/15/2000US6025494 Tetracyclic derivatives, process of preparation and use
02/15/2000US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
02/15/2000US6025396 Stable prostaglandin E1-containing injectable composition
02/15/2000US6025381 3,4-(diphenyl)chromans
02/15/2000US6025166 Human trk receptors and neurotrophic factor inhibitors
02/15/2000CA2058398C 1,4 benzothiazine-2-acetic acid derivatives, processes for production thereof
02/10/2000WO2000006730A2 Human cytoskeletal proteins
02/10/2000WO2000006572A1 Bensoquinolizine derivatives and process for producing the same
02/10/2000WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same
02/10/2000WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000WO2000006568A1 Substituted pyrazole derivatives
02/10/2000WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine
02/10/2000WO2000006531A2 Nitric esters and nitrate salts of specific drugs
02/10/2000WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
02/10/2000WO2000006191A1 Method of treating polycystic ovarian syndrome using igf/igfbp-3
02/10/2000WO2000006187A2 Modulation of apoptosis
02/10/2000WO2000000510A8 Growth factor modulators
02/10/2000WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors
02/10/2000WO1999049038A3 Human calcium-binding proteins
02/10/2000CA2339096A1 Modulation of apoptosis
02/10/2000CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
02/10/2000CA2338699A1 Method of treating polycystic ovarian syndrome using igf/igfbp-3
02/10/2000CA2335656A1 Human cytoskeletal proteins
02/09/2000EP0978282A2 Sublingual composition containing apomorphine for diagnosing functional impotence
02/09/2000EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
02/09/2000EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
02/09/2000EP0977555A1 Pharmaceutical preparations and methods for their regional administration
02/09/2000EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
02/09/2000EP0531407B1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
02/09/2000CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use
02/09/2000CN1243714A Medicine for treating breast addiction and its preparing process
02/09/2000CN1049214C Phenylimidazolidines, process for their preparation, their use as medicament and pharmaceutical compositions containing them.
02/09/2000CN1049116C Process for treating cardiovascular hypertrophy and hyperplasia
02/08/2000US6022978 Benzimidazole derivatives
02/08/2000US6022971 Azetidines
02/08/2000US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development
02/08/2000US6022899 Effective inhibitors of the cellular sodium proton antiporter
02/08/2000US6022539 Injecting collagenase into a fibrous peyronie's plaque in the penis, immobilizing the penis immediately after injection for several hours, collagenase softens and/or ruptures the plaque to ameliorate erectile deviation caused by the plaque
02/03/2000WO2000005260A1 Peptide analogues of pacap
02/03/2000WO2000005225A1 Biphenyl derivatives
02/03/2000WO2000004913A1 Fsh and fsh variant formulations, products and methods
02/03/2000WO2000004880A1 A wet granulation method for preparing a stable pharmaceutical formulation
02/03/2000WO2000004868A2 Libraries of polyhydroxamates and their analogs
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
02/03/2000DE19834507A1 Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil Pharmaceutical, water-soluble tablet formulation for use of sildenafil
02/03/2000DE19834506A1 Transmucosales therapeutisches System zur Anwendung von Sildenafil Transmucosal therapeutic system for the administration of sildenafil
02/03/2000DE19834047A1 Substituierte Pyrazolderivate Substituted pyrazole derivatives
02/03/2000DE19834045A1 (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin (4-amino-5-ethylpyrimidine-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine
02/03/2000DE19834044A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives